Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Total Inventories : ¥7,259 Mil (As of Dec. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Total Inventories?

Shanghai Fosun Pharmaceutical (Group) Co's total inventories for the quarter that ended in Dec. 2024 was ¥7,259 Mil. Shanghai Fosun Pharmaceutical (Group) Co's average total inventories from the quarter that ended in Sep. 2024 to the quarter that ended in Dec. 2024 was ¥7,347 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Shanghai Fosun Pharmaceutical (Group) Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was ¥-16.65.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Shanghai Fosun Pharmaceutical (Group) Co's Days Inventory for the three months ended in Dec. 2024 was 122.43.

Inventory Turnover measures how fast the company turns over its inventory within a year. Shanghai Fosun Pharmaceutical (Group) Co's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.75.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Shanghai Fosun Pharmaceutical (Group) Co's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.72.

Shanghai Fosun Pharmaceutical (Group) Co Total Inventories Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Total Inventories Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Inventories

Get a 7-Day Free Trial

5,162.80

5,472.55

6,882.43

7,537.77

7,258.65

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Inventories	Get a 7-Day Free Trial															7,537.77	7,294.69	7,511.70	7,435.23	7,258.65

Shanghai Fosun Pharmaceutical (Group) Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Shanghai Fosun Pharmaceutical (Group) Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

	Net-Net Working Capital Per Share (Q: Dec. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(16119.93	+	0.75 * 7952.073	+	0.5 * 7258.649	-	57526.838
-	0	-	12672.622)	/	2671.326
=	-16.65

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Shanghai Fosun Pharmaceutical (Group) Co's Days Inventory for the three months ended in Dec. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2024 )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
	=	7346.938	/	5475.975	*	365 / 4
	=	122.43

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Shanghai Fosun Pharmaceutical (Group) Co's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2024 )	/	Average Total Inventories (Q: Dec. 2024 )
	=	5475.975	/	7346.938
	=	0.75

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Shanghai Fosun Pharmaceutical (Group) Co's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	7346.938	/	10155.307
	=	0.72

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Shanghai Fosun Pharmaceutical (Group) Co Total Inventories Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) » Definitions » Total Inventories

Traded in Other Exchanges

SFOSF:USA 02196:Hong Kong 08HH:Germany

Address

No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233

Website

https://www.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.

Executives

Yao Fang	Director
Wu Yi Fang	Director
Wen De Yong	Directors, senior managers
Guan Xiao Hui	Director
Wang Ke Xin	Director
Bao Qin Gui	senior management
Mei Jing Ping	senior management
Li Sheng Li	senior management
Feng Rong Li	senior management
Wang Dong Hua	senior management
Dong Xiao Xian	senior management
Su Li	senior management
Zhu Yue	senior management
Chen Yu Qing	senior management
Hu Hang	senior management

Shanghai Fosun Pharmaceutical (Group) Co Headlines

No Headlines